X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pegaspargase (82) 82
oncology (61) 61
index medicus (55) 55
humans (54) 54
hematology (38) 38
male (37) 37
female (34) 34
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (32) 32
adult (31) 31
asparaginase (31) 31
asparaginase - administration & dosage (31) 31
asparaginase - adverse effects (30) 30
children (28) 28
l-asparaginase (27) 27
chemotherapy (26) 26
adolescent (25) 25
polyethylene glycols - administration & dosage (25) 25
acute lymphoblastic leukemia (24) 24
hypersensitivity (24) 24
therapy (24) 24
pediatrics (23) 23
polyethylene glycols - adverse effects (23) 23
acute lymphoblastic-leukemia (22) 22
treatment outcome (22) 22
leukemia (21) 21
middle aged (21) 21
child (19) 19
antineoplastic agents - adverse effects (17) 17
peg-asparaginase (17) 17
aged (15) 15
asparaginase - therapeutic use (15) 15
cancer (15) 15
gemcitabine (15) 15
induction (15) 15
retrospective studies (15) 15
young adult (15) 15
antineoplastic agents - therapeutic use (14) 14
all (13) 13
antineoplastic combined chemotherapy protocols - therapeutic use (13) 13
antineoplastic agents - administration & dosage (12) 12
child, preschool (12) 12
lymphomas (12) 12
lymphoma, extranodal nk-t-cell - drug therapy (11) 11
pharmacology & pharmacy (11) 11
allergic reactions (10) 10
care and treatment (10) 10
deoxycytidine - analogs & derivatives (10) 10
dexamethasone (10) 10
erwinia asparaginase (10) 10
nasal-type (10) 10
acute lymphocytic leukemia (9) 9
adolescents (9) 9
analysis (9) 9
asparaginase - pharmacokinetics (9) 9
deoxycytidine - administration & dosage (9) 9
drug hypersensitivity - etiology (9) 9
intravenous pegaspargase (9) 9
medical prognosis (9) 9
pharmacokinetics (9) 9
polyethylene glycol (9) 9
antibodies (8) 8
dexamethasone - administration & dosage (8) 8
disease-free survival (8) 8
intravenous (8) 8
lymphoma (8) 8
lymphoma, extranodal nk-t-cell - mortality (8) 8
medicine & public health (8) 8
oxaliplatin (8) 8
polyethylene glycols - therapeutic use (8) 8
prognosis (8) 8
regimen (8) 8
t-cell (8) 8
toxicity (8) 8
acute lymphatic leukemia (7) 7
animals (7) 7
antineoplastic combined chemotherapy protocols - adverse effects (7) 7
e coli (7) 7
escherichia-coli asparaginase (7) 7
intramuscular (7) 7
pegylated asparaginase (7) 7
remission (7) 7
safety (7) 7
t cell lymphoma (7) 7
adults (6) 6
allergic reaction (6) 6
allergy (6) 6
coli l-asparaginase (6) 6
conjugated l-asparaginase (6) 6
drug hypersensitivity - epidemiology (6) 6
efficacy (6) 6
infant (6) 6
lymphatic leukemia (6) 6
patients (6) 6
phase-ii (6) 6
precursor cell lymphoblastic leukemia-lymphoma - complications (6) 6
remission induction (6) 6
t-cell lymphoma (6) 6
young-adults (6) 6
age factors (5) 5
antineoplastic agents (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Leukemia and Lymphoma, ISSN 1042-8194, 07/2018, Volume 59, Issue 7, pp. 1624 - 1633
PEGylated asparaginase (pegaspargase) can be administered via intramuscular (IM) injection or intravenous (IV) infusion with a hypersensitivity reaction (HSR)... 
intramuscular | ALL | hypersensitivity | intravenous | asparaginase | Pegaspargase
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 10/2019, Volume 60, Issue 12, pp. 2854 - 2868
The availability of Erwinia Asparaginase has been limited across the world due to manufacturing shortages or for some countries due to the high acquisition... 
pegaspargase | hypersensitivity | Asparaginase | Erwinia asparaginase | therapeutic drug monitoring
Journal Article
Leukemia Research, ISSN 0145-2126, 03/2018, Volume 66, pp. 49 - 56
Pediatric acute lymphoblastic leukemia (ALL) regimens, including higher cumulative asparaginase doses, have been investigated in adult ALL to improve outcomes.... 
ALL | Adult | Clinical research | Characteristics | Hepatotoxicity | Pegaspargase | YOUNG-ADULTS | L-ASPARAGINASE | REMISSION INDUCTION | CANCER | PEGYLATED-ASPARAGINASE | CHILDREN | TRIAL | THERAPY | ONCOLOGY | ADOLESCENTS | INTRAVENOUS PEGASPARGASE | HEMATOLOGY | Index Medicus
Journal Article
BMC Cancer, ISSN 1471-2407, 09/2018, Volume 18, Issue 1, pp. 910 - 910
Background: The combination of chemotherapy and L-asparaginase (L-ASP) treatment significantly increased survival rate in an adult patient with extranodal... 
Extranodal natural killer (NK)/T-cell lymphoma (NKTCL) | Polyethylene glycol-conjugated asparaginase (pegaspargase | Therapy | Clinical trial | PEG-ASP | L-ASPARAGINASE | PEGASPARGASE | EFFICACY | Polyethylene glycol-conjugated asparaginase (pegaspargase, PEG-ASP) | COMBINATION | REMISSION INDUCTION | CHILDREN | ONCOLOGY | NASAL-TYPE | NATURAL KILLER/T-CELL | ACUTE LYMPHOBLASTIC-LEUKEMIA | EPSTEIN-BARR-VIRUS | Doxorubicin - therapeutic use | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Drug Resistance, Neoplasm | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Neoplasm Metastasis | Lymphoma, Extranodal NK-T-Cell - drug therapy | Lymphoma, Extranodal NK-T-Cell - radiotherapy | Adult | Female | Prednisone - adverse effects | Treatment Outcome | Polyethylene Glycols - administration & dosage | Asparaginase - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Biomarkers | Vincristine - adverse effects | Aged | Lymphoma, Extranodal NK-T-Cell - diagnosis | Neoplasm Staging | Doxorubicin - adverse effects | Prednisone - therapeutic use | Allergy | Treatment outcome | Usage | Care and treatment | Safety and security measures | Research | Allergic reaction | Chemotherapy | T cell lymphoma | Analysis | Chinese | Health aspects | Cancer | Computers | Anthracyclines | Corticosteroids | Mortality | Non-Hodgkin's lymphomas | T cells | Polyols | Fibrin | Services | Cyclophosphamide | Polyethylene glycol | Fibrinogen | Prednisolone | Index Medicus
Journal Article
by Cong, J and Yang, L and Ye, J and Wei, L.Q and Li, X and Wang, J.W
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, ISSN 0253-2727, 08/2018, Volume 39, Issue 8, pp. 654 - 660
Journal Article
PEDIATRIC BLOOD & CANCER, ISSN 1545-5009, 10/2017, Volume 64, Issue 10
BackgroundIncreased toxicities have been identified with higher doses of pegaspargase (PEG-ASP) in adults. This has led to routine use of a dose cap of 3,750IU... 
pegaspargase | THERAPY | ACUTE LYMPHOBLASTIC-LEUKEMIA | PEDIATRICS | INDUCTION | HEMATOLOGY | oncology | CHEMOTHERAPY | pediatric
Journal Article
Chinese Journal of Contemporary Pediatrics, ISSN 1008-8830, 02/2014, Volume 16, Issue 2, pp. 155 - 160
Journal Article
Journal Article
National Medical Journal of China, ISSN 0376-2491, 07/2017, Volume 97, Issue 26, pp. 2047 - 2049
Journal Article
Neoplasma, ISSN 0028-2685, 11/2018, Volume 65, Issue 6, pp. 993 - 997
The incorporation of pegylated asparaginase (PEG-ASP) in pediatric and adult acute lymphoblastic leukemia (ALL) protocols remains a worldwide therapeutic... 
Pegylated asparaginase | Remission | Acute lymphoblastic leukemia | Induction | Toxicity | Asparaginase | toxicity | pegylated asparaginase | induction | PEGASPARGASE | ONCOLOGY | acute lymphoblastic leukemia | asparaginase | remission | ADULT | Index Medicus
Journal Article
Journal Article
Pediatric Hematology and Oncology, ISSN 0888-0018, 07/2019, Volume 36, Issue 5, pp. 277 - 286
Asparaginase is an important component of multi-agent chemotherapy for the treatment of pediatric acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma... 
pegaspargase | hypersensitivity | Acute lymphoblastic leukemia | desensitization | PROTOCOL | CHILDREN | RAPID DESENSITIZATION | THERAPY | ONCOLOGY | GLYCOL CONJUGATED-ASPARAGINASE | BIOLOGY | PEDIATRICS | HEMATOLOGY
Journal Article
Journal of Clinical Apheresis, ISSN 0733-2459, 02/2018, Volume 33, Issue 1, pp. 97 - 98
Journal Article
Journal of Oncology Pharmacy Practice, ISSN 1078-1552, 1/2020, Volume 26, Issue 1, pp. 74 - 92
The incorporation of L-asparaginase and pegylated asparaginase into pediatric-inspired regimens has conferred a survival advantage in treatment of adults with... 
hypersensitivity | pegylated asparaginase | thrombosis | Acute lymphoblastic leukemia | acute myeloid leukemia | asparaginase | hepatotoxicity | pegasparaginase | pancreatitis | coagulopathy | pegaspargase toxicity management
Journal Article
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, ISSN 1077-4114, 03/2019, Volume 41, Issue 2, pp. E125 - E128
Acute pancreatitis in children acute lymphoblastic leukemia is commonly caused by drugs, for example, l-Asparaginase, pegapargase, steroids. The incidence of... 
OCTREOTIDE | pegaspargase | pediatric oncology | ONCOLOGY | acute lymphoblastic leukemia | drug-induced pancreatitis | PEDIATRICS | ASPARAGINASE-ASSOCIATED PANCREATITIS | HEMATOLOGY | children acute pancreatitis
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 04/2018, Volume 59, Issue 4, pp. 855 - 862
We analyzed ammonium levels and acute central nervous complications in adult patients receiving chemotherapy for acute lymphoblastic leukemia with or without... 
ammonium | adult | acute lymphoblastic leukemia | encephalopathy | Asparaginase | Adult | Ammonium | Acute lymphoblastic leukemia | Encephalopathy | YOUNG-ADULTS | PEGASPARGASE | REGIMEN | TOXICITY | CHEMOTHERAPY | CHILDREN | HYPERAMMONEMIC ENCEPHALOPATHY | THERAPY | ONCOLOGY | LYMPHOMA | IDIOPATHIC HYPERAMMONEMIA | HEMATOLOGY
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.